EDGAR Filing Documents for 0001354457-08-000329

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:

SEC Accession No. 0001354457-08-000329

Filing Date

2008-11-14

Accepted

2008-11-14 11:58:02

Documents

Confirming Copy

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	25-NSE
1		primary_doc.xml	25-NSE	1106
2		abpidelistreason.txt	EX-99.25	853
	Complete submission text file	0001354457-08-000329.txt		3881

Mailing Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606

Business Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606 8138642562

ACCENTIA BIOPHARMACEUTICALS INC (Subject) CIK: 0001310094 (see all company filings)

IRS No.: 000000000
Type: 25-NSE | Act: 34 | File No.: 000-51383
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9600 BLACKWELL RD ROCKVILLE MD 20850

Business Address 9600 BLACKWELL RD ROCKVILLE MD 20850 301-978-4144

NASDAQ Stock Market LLC (Filed by) CIK: 0001354457 (see all company filings)

IRS No.: 521165937 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25-NSE